In recent months, markets have reached new record highs, signaling that high-growth potential stocks offer opportunities to multiply earnings. The number of high-wealth individuals in the U.S. grew substantially last year alongside the stock market, partly due to notable gains among artificial intelligence (AI) stocks. Naturally, this sparks significant interest in high-growth potential stocks. Growth stocks appeal because they have the potential to outperform the market. Often, these are businesses newly entering their fields after making unrealized investments. Examples include healthcare firms nearing breakthrough drugs with strong demand, such as Novo Nordisk’s (NYSE:NVO) weight loss medication Ozempic. Another example is a company achieving near market dominance in a suddenly high-demand field, such as Nvidia’s (NASDAQ:NVDA) AI chips. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Identifying stocks capable of increasing investment value 10x can prove tricky. However, those with solid sales growth and large market share in expanding industries typically offer high growth potential. Beam Therapeutics (BEAM) Scientists in a lab Source: Matej Kastelic / Shutterstock Beam Therapeutics (NASDAQ:BEAM) develops and markets precision genetic medicines and has experienced stock price volatility this year. The company works on several potential treatments for serious diseases using its patented gene-editing technology. One of those includes an expected therapy for sickle cell disease, with study results expected in the second half of the year. The BEAM share price nearly doubled ahead of strong fourth-quarter results. However, it has declined again as analysts adjusted outlooks based on anticipated revenue timelines and trial completions. However, the price target was maintained, suggesting the underlying business value and growth potential remain intact. Currently, Beam is one of the high-growth potential stocks that can achieve 10x potential gains as its therapies reach the market and sales increase. The company has $1.09 billion in cash reserves, estimated to fund operations through 2027 if needed. Most analysts recommend purchasing BEAM stock, with an average price target of $48.64, indicating over 110% upside potential. Booking Holdings (BKNG) a person opens up Booking.com on a smartphone Source: Denys Prykhodov / Shutterstock.com Booking Holdings (NASDAQ:BKNG) is the leading online hotel and travel booking company and one of the high-growth potential stocks to multiply your earnings. It owns several major websites, including booking.com, priceline.com, Kayak, Cheapflights and rentalcars.com. Over the last year, the BKNG share price has grown substantially, increasing 44%, as the travel industry expects 2024 to be another record year for travel. In the online booking sector, Booking maintains the largest and majority market share, which is expected to double by the end of the decade as global travel recovers from Covid. Excluding the pandemic period, gross bookings have grown 24% over the last year. Net income nearly doubled from the prior year, though some recovery from the pandemic is still reflected. With earnings growing at 191.7% year-over-year (YOY) and much faster than its stock price, further room for growth remains. This is especially true as the company maintains a solid profit margin of 21.8% and revenue growth of 16.9%. VICI Properties (VICI) Person holding mobile phone with logo of American real estate company Vici Properties Inc. on screen in front of web page. VICI stock. Source: T. Schneider / Shutterstock VICI Properties (NYSE:VICI) is a real estate investment trust (REIT) that invests in casinos, hospitality and related entertainment venues, such as restaurants and hotels. The gambling industry has seen record growth in recent years, increasing by 10% just last year alone. This positive trend has continued into 2024, with the first quarter also achieving record performance levels. VICI Properties pays a healthy dividend yield of 6%, making it suitable for dividend-focused investors. However, its strong sales and double-digit earnings growth YOY and its profit margin of 70.1% position it as one of the high-growth potential stocks. It offers an interesting option for traders seeking both growth and lower risk. VICI stock currently trades at a P/E ratio of just 11x, significantly below the average of 30x for the S&P 500 index. Despite the VICI share price declining 13% year-to-date (YTD), all 21 analysts recommend buying at current levels as the company continues to deliver consistent revenue growth. Jefferies analyst David Katz has a price target with a potential 58% upside from current levels. On the date of publication, Stavros Tousios did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.comPublishing Guidelines. On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article. Stavros Tousios, MBA, is the founder and chief analyst at Markets Untold. With expertise in FX, macros, equity analysis, and investment advisory, Stavros delivers investors strategic guidance and valuable insights. More From InvestorPlace Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future” The post 3 Stocks With the Potential to 10X Your Money appeared first on InvestorPlace.
3 Stocks With the Potential to 10X Your Money
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...